Advent Pharma Ltd. Company Information & Result

~Congratulation Lottery Winner~

DOWNLOAD LOTTERY RESULT HERE: Published

Update: Total Applied 35.17 Gun, General Applied (986,349)=77.05 Gun, Affected Applied ( 99,929)= 31.22 Gun, NRB Applied = (65,274)16.31 Gun, Mutual Fund Applied (24,000)= 6 Gun, Institute Appiled = 14.01 Gun.

Update: Lottery date 13 March’2018 at 10.30 am in Engineering Institute, Ramna, Dhaka.

The Bangladesh Securities Exchange Commission (BSEC) approved IPO Advent Pharma Ltd. on Tuesday, 02 January 2018 at their 622 nos Board Meeting. Presided by BSEC Chairman Prof. Dr. M Khairul Hossain to issue 2.00 crore ordinary shares worth Tk 10 each. Company Information, IPO Application Form, Prospectus & Result is given below:

COMPANY INFORMATION:

Company Name: Advent Pharma Limited (APL)
Incorporation: The company was incorporated on 25 January 2007 as a private limited Company and was subsequently converted into a public limited company on 7th May 2016.
Commercial Operation: APL was started commercial operation on 1st March 2013.
Authorized Capital: Tk. 1,000,000,000 divided into 100,000,000 ordinary shares of Tk. 10.00 each
Paid Up Capital (Before IPO): Tk. 486,000,000 divided into 48,600,000 ordinary shares of Tk. 10.00 each
Paid Up Capital (After IPO): Tk. 686,000,000 divided into 68,600,000 ordinary shares of Tk. 10.00 each

Management Body: 1) Wajhi Ahmed, Chairman
2) Mohammad Jawaid Yahya, Managing Director & Director
3) Kazi Rina Alam, Director
4) Faria Binta Alam, Director
5) Mahmood Ali, (Nominee Director of Blue Agro Tech Ltd.)
6) Mohammad Towhidul Islam, (Nominee Director of Horipur Feed Ltd.)
7) Md. Tazul Islam, Director
8) Asif Iqbal Chowdhury, (Nominee Director of Farmers Hope Ltd.)
9) Mohammed Salim, Independent Director
10) Shanzida Akhter Khanam, Independent Director

NATURE OF BUSINESS:

The Company is a Pharmaceutical company which is engaged in manufacturing, importing and marketing of animal health care drugs, nutritional supplements and feed additives for livestock like powder, bolus and

liquid dosage forms.

PRODUCT:

Advent Pharma Ltd. details product list : Click Here

ADDRESS:

Corporate Office:

Green Homes, Block – A, Flat # 2 B, House 10/7,
Iqbal road, Mohammadpur, Dhaka-1207.
Phone: +88-02-9185351, 9185352

Registered Office & Factory:

Plot # B 50-54 BSCIC Industrial Estate,
Kalampur, Dhamrai, Dhaka-1351.
Mobile No # 01829-672833
Email: plant@adventpharmabd.com
Web Address: www.adventpharmabd.com

MAJOR FINANCIAL INFORMATION AS FOLLOWS:

Figure in Tk.’000

Particulars	31-12-16 (6 Months)	30-06-16 (18 Months)	31-12-14	31-12-13	31-12-12	31-12-11
Revenue	130,220	330,967	165,737	122,768	–	–
Gross Profit	55,635	137,555	66,537	50,035	–	–
Net Profit before tax	27,682	63,582	26,712	18,703	–	–
Net Profit after tax	17,993	41,328	17,363	11,689	–	–
Total Assets	658,248	327,056	141,293	107,715	82,724	63,265
Share Capital	486,000	99,900	30,500	30,500	4,500	4,500
Retained Earnings	88,576	70,583	29,255	11,689	–	–
No. of Shares	48,600	9,990	3,050	3,050	450	450
Face Value	10.00	10.00	100.00	100.00	100.00	100.00
NAV per Shares (With revaluation reserve)	11.82	17.07	1,959.17	1,383.26	100.00	100.00
Earnings per Share (Basic)	1.05	8.48	569.26	635.62	–	–

ADVENT PHARMA LTD. EPS & NAV:

As per company’s year ended financial statement on 30 June 2017, Advent Pharma Ltd. stands Net Assets Value per shares (NAV) without revaluation Tk. 12.42 and last four years Weighted Average Earning Per Shares (EPS) Tk. 0.91.

ISSUE MANAGER:

Imperial Capital Ltd., Alpha Capital Management Ltd. and CAPM Advisory Ltd. are jointly working as the manager to the issue.

WHY PUBLIC OFFERING:

Bangladesh Securities Exchange Commission (BSEC) approved IPO of above Co. on 02 January 2018. The companies will raise a fund worth Tk. 200.00 million for the purpose of acquisition of Machinery & Equipment, Construction and other civil works and for IPO Expenses.

NOS. OF SHARE OFFER: 2,00,00,000
VALUE OF IPO: Tk. 200,000,000/=
FACE VALUE: Tk. 10/=
PREMIUM VALUE: Nil
MARKET LOT: 500
MINIMUM LOT VALUE: Tk.5000/=
SHARE ALLOTMENT: 40% for General Public and Affected Investors=16,000 lot, 40% for Eligible Investor (EI) =16,000 lot, 10% for NRB = 4,000 lot and 10% for Mutual Fund = 4,000 lot.

** The Company will collect IPO money through BSEC new rules and the new rule is “BROKER HOUSE SHOULD COLLECT IPO MONEY ONLY”.